AgNovos Research Interests
AgNovos Bioscience is focused on bone health
AgNovos recognizes that we must work with our partners in healthcare to change the world for millions of individuals who suffer from bone disease. AgNovos' first investigational treatment targets individuals with osteoporosis. We are always interested in better understanding the science that underpins bone disease and our treatment.
AgNovos has established an Investigator-Sponsored Trial (IST) program to support independent researchers who are interested in studying our technology and/or bone disease.
The IST program at AgNovos supports research that can advance knowledge of the scientific, medical or health economic challenges of bone disease and the opportunities that may be presented through the use of OSSURE™ LOEP (Local Osteo-Enhancement Procedure). Results of such studies may lead to greater understanding of osteoporosis, other bone diseases, and/or other opportunities to improve patient care.
Who may propose research?
Researchers may propose the following types of studies for evaluation:
- Prospective and retrospective clinical studies with approved AgNovos technology
- Observational studies, such as epidemiological research on diseases of interest. Osteoporosis is our current focus
How can we help?
Please complete the inquiry form below so we can route your inquiry appropriately. A member of the AgNovos medical team will be in touch with you within the next few days to advise of the status of your request and explain the overall process.